AB321. SPR-48 The effects of myrbetriq on detrusor overactivity associated with suprasacral spinal cord injury (SCI) in rats

OBJECTIVE: β3-adrenoceptor agonists (BARA) represent a novel mechanism of action for direct relaxation of urinary bladder smooth muscle. Myrbetriq (MYR) is an FDA approved BARA developed by Astellas Pharma, and has proven to be very useful for treating overactive bladder. Preliminary data from this...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Androl Urol
Hlavní autoři: Brooks, Jillene M., Degoski, Danielle J., Fraser, Matthew O.
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2016
Témata:
Abstract
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5143270/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2016.s321
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky